ArticleRSC advances2023

Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostat.

Yali Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.